See more : Beijing Dinghan Technology Group Co.Ltd (300011.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of PHC Holdings Corporation (6523.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PHC Holdings Corporation, a leading company in the Medical – Devices industry within the Healthcare sector.
- JINS HOLDINGS Inc. (3046.T) Income Statement Analysis – Financial Results
- InterPrivate III Financial Partners Inc. (IPVF-UN) Income Statement Analysis – Financial Results
- Volkswagen AG (VWAGY) Income Statement Analysis – Financial Results
- Associated British Foods plc (ABF.L) Income Statement Analysis – Financial Results
- Simon Property Group Acquisitio (SPGS-WT) Income Statement Analysis – Financial Results
PHC Holdings Corporation (6523.T)
About PHC Holdings Corporation
PHC Holdings Corporation, through its subsidiaries, develops, manufactures, and sells medical devices, healthcare technology solutions, and life science products. The company offers blood glucose monitoring systems and other testing/analysis devices, as well as data linkage solutions; anatomical pathology solutions, such as instruments, microscope slides, and dyeing reagents; and equipment and services for various sample preservation and cell culture in the life sciences field. It also provides healthcare IT products in the field of medical information systems for clinics and healthcare insurance pharmacies. In addition, the company engages in clinical testing, diagnostic reagents, and drug development support businesses. The company was formerly known as Panasonic Healthcare Holdings Co., Ltd. and changed its name to PHC Holdings Corporation in April 2018. The company was founded in 2014 and is headquartered in Tokyo, Japan.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 353.90B | 356.43B | 340.45B | 306.07B | 272.64B | 186.55B |
Cost of Revenue | 195.93B | 187.30B | 175.21B | 162.42B | 135.05B | 69.21B |
Gross Profit | 157.98B | 169.13B | 165.24B | 143.65B | 137.59B | 117.34B |
Gross Profit Ratio | 44.64% | 47.45% | 48.53% | 46.93% | 50.47% | 62.90% |
Research & Development | 11.97B | 9.93B | 10.26B | 15.71B | 14.71B | 13.20B |
General & Administrative | 121.12B | 140.66B | 142.20B | 129.65B | 123.42B | 94.24B |
Selling & Marketing | 10.39B | 9.03B | 6.32B | 0.00 | 0.00 | 0.00 |
SG&A | 131.51B | 140.66B | 142.20B | 129.65B | 123.42B | 94.24B |
Other Expenses | 6.19B | 0.00 | 14.51B | -3.93B | 930.00M | 358.00M |
Operating Expenses | 149.66B | 148.62B | 156.71B | 125.72B | 124.35B | 94.59B |
Cost & Expenses | 345.59B | 335.92B | 331.92B | 288.14B | 259.40B | 163.80B |
Interest Income | 358.00M | 411.00M | 2.35B | 16.32B | 163.00M | 205.00M |
Interest Expense | 15.46B | 20.23B | 7.52B | 11.13B | 7.73B | 2.30B |
Depreciation & Amortization | 27.93B | 29.02B | 31.08B | 30.37B | 26.92B | 16.16B |
EBITDA | 30.15B | 58.43B | 56.89B | 62.29B | 38.26B | 38.69B |
EBITDA Ratio | 8.52% | 13.87% | 12.22% | 21.00% | 14.77% | 20.96% |
Operating Income | 8.31B | 20.00B | 8.17B | 17.60B | 13.18B | 22.75B |
Operating Income Ratio | 2.35% | 5.61% | 2.40% | 5.75% | 4.83% | 12.19% |
Total Other Income/Expenses | -21.56B | -28.30B | -5.17B | 5.19B | -7.57B | -2.10B |
Income Before Tax | -13.25B | 179.00M | 3.00B | 22.79B | 5.61B | 20.65B |
Income Before Tax Ratio | -3.74% | 0.05% | 0.88% | 7.45% | 2.06% | 11.07% |
Income Tax Expense | -391.00M | 3.23B | 11.30B | 5.96B | 299.00M | 5.21B |
Net Income | -12.89B | -3.22B | -8.46B | 16.91B | 5.28B | 15.45B |
Net Income Ratio | -3.64% | -0.90% | -2.48% | 5.52% | 1.94% | 8.28% |
EPS | -102.48 | -25.83 | -70.78 | 138.38 | 43.19 | 130.45 |
EPS Diluted | -102.48 | -25.83 | -70.78 | 138.38 | 43.19 | 130.11 |
Weighted Avg Shares Out | 125.81M | 124.69M | 119.53M | 122.17M | 122.17M | 118.46M |
Weighted Avg Shares Out (Dil) | 125.81M | 124.69M | 119.53M | 122.17M | 122.17M | 118.76M |
Source: https://incomestatements.info
Category: Stock Reports